with 9 state-of-the-art technological platforms
MISSION
The human induced pluripotent stem cell (iPSc) technology is a powerful tool to create unique human disease-relevant models, to study molecular and cellular pathological mechanisms, and for drug screening approaches.
The Brain Institute (ICM, Paris) acquired this technology in 2013 to promote forefront basic and preclinical research programs for neurodegenerative diseases. Today the core facility ICV–iPS proposes the generation and the genetic engineering of human iPS cells to internal research teams, external academic teams, and industrial partners. The IHU-A-ICM funding supports this activity.
SERVICES
- Generation of human iPSc
- Full molecular and functional characterization of iPSc clones
- Genetic engineering of human iPSc
- Generation of human iPS-derived neural stem cells
- Theoretical and practical learning sessions on human iPSc culture
- Access to a L2 cell culture box dedicated to human iPSc culture